Optomed Oyj

Optomed is a Finnish health technology company specializing in handheld fundus cameras and screening software solutions. The company integrates its devices with software and AI to revolutionize the diagnosis process of diseases like diabetic retinopathy. Optomed operates globally, with offices in Finland, the USA, and China, and distributes its products in over 60 countries. The company is transitioning from innovation-driven development to large-scale commercial deployment, focusing on integrating its technology into primary healthcare settings.

111

2.39

1.94

— Optomed Oyj
%
Fundus Cameras50% Handheld devices for retinal imaging.
Screening Software30% Software solutions for disease screening.
AI Solutions10% AI integration for enhanced diagnostic accuracy.
Clinical Solutions10% Comprehensive solutions for clinical environments.

Optomed's customer base primarily includes healthcare providers such as hospitals, clinics, and eye care specialists...

  • Healthcare Providersprimary

    Hospitals and clinics purchasing diagnostic tools for retinal imaging.

  • Eye Care Specialistssecondary

    Specialists using fundus cameras for detailed eye examinations.

  • Healthcare Systemsemerging

    Systems integrating AI solutions for enhanced diagnostic processes.

Optomed operates internationally, with key offices in Finland, the USA, and China. Its products are distributed in over...

  • Headquartered in Finland with offices in USA and China
  • Products distributed in over 60 countries
  • Manufacturing operations based in Thailand
  • Key market presence in the USA for advanced healthcare access

Optomed's strategic priorities include expanding its market presence by scaling its commercial operations and...

01
Commercial Expansionmedium-term

To increase market presence and sales.

02
AI Integrationlong-term

To improve diagnostic accuracy and efficiency.

03
Product Usabilityshort-term

To enhance user experience and workflow efficiency.

Optomed faces several risks including geopolitical tensions that could impact its supply chain and sales...

critical

Product Quality

Essential for maintaining competitive edge.

Materiality
high
high

Geopolitical Tensions

Could disrupt supply chain and increase costs.

Materiality
high
high

Regulatory Compliance

Complex international regulations pose challenges.

Materiality
medium
Revenue Recognition
Inventory Valuation
R&D Expenses

: 11/08/2026